These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 14363211

  • 1. The estimation of tryptophan metabolites in the urine of patients with cancer of the bladder.
    BOYLAND E, WILLIAMS DC.
    Biochem J; 1955 Mar 19; 60(Annual General Meeting):v. PubMed ID: 14363211
    [No Abstract] [Full Text] [Related]

  • 2. [Research on the metabolites resulting from the conversion of tryptophan to nicotinic acid in the urine of patients with bladder neoplasms].
    FEDELE L, TANCREDI F, RICCARDI I.
    Minerva Urol; 1961 Mar 19; 13():1-3. PubMed ID: 13698505
    [No Abstract] [Full Text] [Related]

  • 3. [Tryptophan metabolites in the urine of patients with cancer of the urinary bladder].
    Kvirikadze NA.
    Vopr Onkol; 1970 Mar 19; 16(12):76. PubMed ID: 5516762
    [No Abstract] [Full Text] [Related]

  • 4. L-tryptophan metabolites and bladder cancer.
    Ebinger G, Michotte Y.
    J Rheumatol; 1991 Nov 19; 18(11):1771. PubMed ID: 1787510
    [No Abstract] [Full Text] [Related]

  • 5. [Cancer of the urinary bladder and tryptophan metabolism].
    Koike R.
    Hinyokika Kiyo; 1966 Jan 19; 12(1):1-2. PubMed ID: 5950230
    [No Abstract] [Full Text] [Related]

  • 6. Tryptophan metabolites in the urine of Turkish cows with urinary bladder cancer.
    PAMUKCU AM, BROWN RR, PRICE JM.
    Cancer Res; 1959 Apr 19; 19(3 Pt 1):321-5. PubMed ID: 13638980
    [No Abstract] [Full Text] [Related]

  • 7. Tryptophan metabolism in patients with bladder cancer: geographical differences.
    Brown RR, Price JM, Friedell GH, Burney SW.
    J Natl Cancer Inst; 1969 Jul 19; 43(1):295-301. PubMed ID: 5796394
    [No Abstract] [Full Text] [Related]

  • 8. Studies on the urinary excretion of certain tryptophan metabolites in bilharziasis and its possible relation to bladder cancer in Egypt.
    ABUL-FADL MA, KHALAFALLAH AS.
    Br J Cancer; 1961 Sep 19; 15(3):479-82. PubMed ID: 13859104
    [No Abstract] [Full Text] [Related]

  • 9. Tryptophan, urinary quinolines, and bladder cancer.
    Williams DJ.
    Nutr Cancer; 1988 Sep 19; 11(2):81-2. PubMed ID: 3283708
    [No Abstract] [Full Text] [Related]

  • 10. [Study of tryptophan carcinogenic metabolites as haptens].
    Korosteleva TA, Krutova EN, Zasypka AT.
    Vopr Onkol; 1966 Sep 19; 12(2):44-9. PubMed ID: 5982622
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer].
    Kitsukawa S, Yamamoto Y, Hosoda S, Otsuru N, Matsumoto T, Matsumoto T, Aizawa T, Noda K, Ito T.
    Hinyokika Kiyo; 2006 Mar 19; 52(3):167-72. PubMed ID: 16617867
    [Abstract] [Full Text] [Related]

  • 12. [Studies on the metabolic conversion of tryptophan into nicotinic acid in individuals with tumors of the bladder. Modifications in the urinary excretory picture after the administration of nicotinamide and vitamin B6].
    SACCONE C, TANCREDI F, FEDELE L, QUAGLIARIELLO E.
    Boll Soc Ital Biol Sper; 1960 Dec 31; 36():1942-3. PubMed ID: 13745208
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer.
    Stejskal D, Fiala RR.
    Neoplasma; 2006 Dec 31; 53(4):343-6. PubMed ID: 16830064
    [Abstract] [Full Text] [Related]

  • 14. A possible role of urinary metabolites of tryptophan in the heterotopic recurrence of bladder cancer in man.
    Yoshida O, Brown RR, Bryan GT.
    Am J Clin Nutr; 1971 Jul 31; 24(7):848-51. PubMed ID: 5091525
    [No Abstract] [Full Text] [Related]

  • 15. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
    Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U, Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB.
    Eur Urol; 2004 Oct 31; 46(4):466-71. PubMed ID: 15363562
    [Abstract] [Full Text] [Related]

  • 16. Urine dendritic cells: a noninvasive probe for immune activity in bladder cancer?
    Beatty JD, Islam S, North ME, Knight SC, Ogden CW.
    BJU Int; 2004 Dec 31; 94(9):1377-83. PubMed ID: 15610124
    [Abstract] [Full Text] [Related]

  • 17. The metabolism of tryptophan. 2. The metabolism of tryptophan in patients suffering from cancer of the bladder.
    BOYLAND E, WILLIAMS DC.
    Biochem J; 1956 Nov 31; 64(3):578-82. PubMed ID: 13373811
    [No Abstract] [Full Text] [Related]

  • 18. Can the levels of nitric oxide in the urine, serum and tumor tissue be putative markers for bladder cancer?
    Kiliç S, Bayraktar N, Beytur A, Ergin H, Bayraktar M, Egri M.
    Int J Urol; 2006 Aug 31; 13(8):1079-85. PubMed ID: 16903933
    [Abstract] [Full Text] [Related]

  • 19. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
    Tzai TS, Tsai YS, Shiau AL, Wu CL, Shieh GS, Tsai HT.
    Urology; 2006 Feb 31; 67(2):294-9. PubMed ID: 16461079
    [Abstract] [Full Text] [Related]

  • 20. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
    Friedrich MG, Weisenberger DJ, Cheng JC, Chandrasoma S, Siegmund KD, Gonzalgo ML, Toma MI, Huland H, Yoo C, Tsai YC, Nichols PW, Bochner BH, Jones PA, Liang G.
    Clin Cancer Res; 2004 Nov 15; 10(22):7457-65. PubMed ID: 15569975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.